Roots Analysis

FEBRUARY 18, 2022

Over time, many research studies have shown that myeloid cells can interact with the immune system and aid in generating an appropriate anti-tumor immune response. The key focus of these studies is on the development of anti-tumor therapeutics. CLINICAL TRIALS EVALUATING MYELOID CELLS TAREGTING THERAPEUTICS.

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

MARCH 3, 2022

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Currently, nine complement therapeutics are commercially available, while around 190 molecules are under development for various disease indications. Next Generation Complement Therapeutics. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

Roots Analysis

MAY 21, 2024

Amidst the ongoing initiatives to develop therapeutic interventions with improved bioavailability, lipid nanoparticle (LNPs) have specifically attracted the attention of researchers and drug developers. In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40

Drug Discovery World

FEBRUARY 5, 2024

Utilising our integrated experimental biology and machine learning platform to realise the power of large-scale, systemic data, we are developing a preclinical pipeline of targeted oncology therapeutics in biomarker-defined settings — reinventing the traditional approach to target and drug discovery.

Research 116

Research Gene Sequencing Drug Delivery Systems Trials 116

STAT News

NOVEMBER 3, 2022

The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing The single-dose vaccine candidate is a combination of Pfizer’s mRNA-based flu shot and the Omicron-tailored Covid-19 booster shot developed by both companies.

Vaccination 97

Vaccination Vaccine Drug Delivery Systems Sales 97

Pharmaceutical Technology

APRIL 24, 2023

In 1974, Dr. Robert Langer was part of the first cohort of researchers to begin nanoparticle research , as his lab at Cornell University developed tiny particles to deliver large molecules for angiogenesis. The next wave came from early research into liposomes and lipid nanoparticles, both of which are used for drug delivery.

Drug Delivery 147

Drug Delivery Vaccination Vaccine Research 147